250 related articles for article (PubMed ID: 36805873)
1. Nanotechnology for next-generation cancer immunotherapy: State of the art and future perspectives.
Chen Y
J Control Release; 2023 Apr; 356():14-25. PubMed ID: 36805873
[TBL] [Abstract][Full Text] [Related]
2. Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response.
Wang QT; Liu YX; Wang J; Wang H
ChemMedChem; 2023 Jul; 18(13):e202200673. PubMed ID: 37088719
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
4. Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.
Lan H; Zhang W; Jin K; Liu Y; Wang Z
Drug Deliv; 2020 Dec; 27(1):1248-1262. PubMed ID: 32865029
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
7. Application of nanotechnology in circumventing immunotolerance.
Ma Y; Shen Y; Zhu B; Li D; Liu J
Pharmazie; 2020 Oct; 75(10):470-477. PubMed ID: 33305719
[TBL] [Abstract][Full Text] [Related]
8. Nanocatalysts for modulating antitumor immunity: fabrication, mechanisms and applications.
Wu X; Li Y; Wen M; Xie Y; Zeng K; Liu YN; Chen W; Zhao Y
Chem Soc Rev; 2024 Mar; 53(5):2643-2692. PubMed ID: 38314836
[TBL] [Abstract][Full Text] [Related]
9. Nano-Enhanced Cancer Immunotherapy: Immunology Encounters Nanotechnology.
Bockamp E; Rosigkeit S; Siegl D; Schuppan D
Cells; 2020 Sep; 9(9):. PubMed ID: 32942725
[TBL] [Abstract][Full Text] [Related]
10. Advances in Nanotechnology-Based Immunotherapy for Glioblastoma.
Tang L; Zhang M; Liu C
Front Immunol; 2022; 13():882257. PubMed ID: 35651605
[TBL] [Abstract][Full Text] [Related]
11. A new approach to overcoming resistance to immunotherapy: nanotechnology.
Shao J; Jin Y; Jin C
Front Oncol; 2023; 13():1210245. PubMed ID: 37637050
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology Reprogramming Metabolism for Enhanced Tumor Immunotherapy.
Zhou Y; Yuan J; Xu K; Li S; Liu Y
ACS Nano; 2024 Jan; 18(3):1846-1864. PubMed ID: 38180952
[TBL] [Abstract][Full Text] [Related]
13. Recent advancements in immunotherapy of melanoma using nanotechnology-based strategies.
Bahreyni A; Mohamud Y; Luo H
Biomed Pharmacother; 2023 Mar; 159():114243. PubMed ID: 36641926
[TBL] [Abstract][Full Text] [Related]
14. Nanovaccines in cancer immunotherapy: Focusing on dendritic cell targeting.
Achmad H; Saleh Ibrahim Y; Mohammed Al-Taee M; Gabr GA; Waheed Riaz M; Hamoud Alshahrani S; Alexis RamÃrez-Coronel A; Turki Jalil A; Setia Budi H; Sawitri W; Elena Stanislavovna M; Gupta J
Int Immunopharmacol; 2022 Dec; 113(Pt B):109434. PubMed ID: 36402068
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology-based photo-immunotherapy: a new hope for inhibition of melanoma growth and metastasis.
Zhang JY; Gao WD; Lin JY; Xu S; Zhang LJ; Lu XC; Luan X; Peng JQ; Chen Y
J Drug Target; 2023 Jul; 31(6):555-568. PubMed ID: 37216425
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology for the Development of Nanovaccines in Cancer Immunotherapy.
Grimaudo MA
Adv Exp Med Biol; 2021; 1295():303-315. PubMed ID: 33543465
[TBL] [Abstract][Full Text] [Related]
17. Enhancing Cancer Immunotherapeutic Efficacy with Sonotheranostic Strategies.
Zafar A; Hasan M; Tariq T; Dai Z
Bioconjug Chem; 2022 Jun; 33(6):1011-1034. PubMed ID: 34793138
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
[TBL] [Abstract][Full Text] [Related]
19. Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions.
Li Y; Li S; Jiang Z; Tan K; Meng Y; Zhang D; Ma X
J Nanobiotechnology; 2023 Jul; 21(1):212. PubMed ID: 37415161
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for tumor immunotherapy.
Zang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Eur J Pharm Biopharm; 2017 Jun; 115():243-256. PubMed ID: 28323111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
